Visage Imaging says it will introduce at the RSNA meeting the world’s first thin client PACS with native Mac support.
Visage Imaging says it will introduce at the RSNA meeting the world’s first thin client PACS with native Mac support. Visage 7, the company’s new generation diagnostic imaging IT product, is designed to serve as a “thin viewing layer” on top of an existing PACS. It can also serve as a turnkey solution serving as a radiology information system and archive, as well as a viewing, and post processing workstation. Visage 7 is based on a new generation of the Visage thin client technology, which has been optimized for speed and versatility, as well as extended to natively support the Mac OS X platform, according to the company, a wholly owned subsidiary of Pro Medicus.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.